Science Explorer Back to mapMap
Discussion
Researcher · National Institute of Allergy and Infectious Diseases · United States

Mark Connors

Mark Connors publishes mostly in Immunology, Virology and Epidemiology, on topics such as HIV Research and Treatment, Immune Cell Function and Interaction and T-cell and B-cell Immunology.

ORCID 0000-0002-2108-8705 OpenAlex
World rank
#38,823
of 7,710,434 ranked researchers
Rank in United States
#14,853
of 1,627,098
Works
194
Citations
27k
Citations per work
141.0
h-index
76
i10-index 134Top 1.1% in Immunology
Mark Connors

What does Mark Connors research?

Mark Connors's work is mostly in Immunology and Microbiology (59%), Medicine (27%), Biochemistry, Genetics and Molecular Biology (3%).

Life Sciences: 121 works · 62.3% of their workImmunology and Microbiology: 115 works · 59.3% of their workImmunology: 67 works · 34.4% of their workVirology: 48 works · 24.9% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 3.0% of their workMolecular Biology: 6 works · 3.0% of their workHealth Sciences: 52 works · 26.8% of their workMedicine: 52 works · 26.8% of their workEpidemiology: 22 works · 11.5% of their workInfectious Diseases: 19 works · 9.9% of their workRadiology, Nuclear Medicine and Imaging: 10 works · 5.4% of their workEverything else: 21 works · 10.9% of their workTHEIR WORKMark Connors194works
Life Sciences62%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology11559.3%
    2. Biochemistry, Genetics and Molecular Biology63.0%
    1. Medicine5226.8%
  3. Everything else2110.9%
  1. 1Immunology34% of their works
  2. 2Virology25% of their works
  3. 3Epidemiology12% of their works
  4. 4Infectious Diseases10% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Mark Connors's research?

The keywords of their largest research topics: Antiretroviral Therapy, AIDS, HIV, Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß and Cytomegalovirus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Antiretroviral Therapy1863 topics
  2. AIDS1391 topic
  3. HIV1391 topic
  4. NK Cell Recognition1011 topic
  5. Natural Killer Cells1011 topic
  6. Foxp3601 topic
  7. TGF-ß601 topic
  8. Cytomegalovirus321 topic
  9. Infection321 topic
  10. Fc Receptors301 topic
  11. Therapeutic Antibodies301 topic
  12. Drug Resistance271 topic
  13. HIV Infection271 topic
  14. HIV Transmission201 topic
  15. Preexposure Prophylaxis201 topic
  16. Dendritic Cells151 topic
  17. Immunity151 topic

Where does Mark Connors work?

Mark Connors's main affiliation in the publication record is National Institute of Allergy and Infectious Diseases, United States.

How many publications and citations does Mark Connors have?

OpenAlex counts 194 works and 27,358 citations for Mark Connors, an h-index of 76, ranking #38,823 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Connors. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.